Monday, December 30, 2019

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer.

from Moneycontrol Business News https://ift.tt/35awRrv

No comments:

Post a Comment

Dollar stays near 18-month high as Mideast conflict, inflation data in focus

The dollar's steadiness reflects a cautious market responding to geopolitical stresses in the Middle East, which have dampened investor ...